Onyia Jude

CIK 00018944252 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001894425

Recent Transactions

50 trades

Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2026-06-09+30,000→ 30,000 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-06-05−2,441→ 23,405 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-06-01$84.74/sh+11,000→ 36,846 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2026-06-01−11,000→ 13,268 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-06-01$160.25/sh−11,000→ 25,846 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-05-27$155.53/sh−11,000→ 25,846 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2026-05-27−11,000→ 24,268 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-05-27$84.74/sh+11,000→ 36,846 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-20−3,110→ 25,670 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13+2,690→ 19,801 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13+2,717→ 21,066 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13+19,935→ 39,535 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13$124.12/sh−1,466→ 19,600 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13$124.12/sh−1,452→ 18,349 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-13+9,669→ 9,669 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2026-02-13+55,119→ 55,119 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-13−2,717→ 2,717 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-13−2,690→ 5,380 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-13$124.12/sh−10,755→ 28,780 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-12$123.10/sh−1,426→ 17,111 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-02-12+2,560→ 18,537 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-02-12−2,560→ 7,681 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2026-01-31−238→ 0 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-31+238→ 16,119 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2026-01-31$136.06/sh−142→ 15,977 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-29+4,426→ 18,129 total
Tax Payment
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-11-29$152.16/sh−2,248→ 15,881 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-11-29−4,426→ 0 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-09-03−1,470→ 13,703 total
Gift
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-08-05−3,116→ 15,173 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-07-09−59,819→ 35,268 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-07-09$130.46/sh−59,819→ 18,289 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-07-09$84.74/sh+59,819→ 78,108 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2025-07-02−20,362→ 95,087 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-07-02$84.74/sh+20,362→ 38,651 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-07-02$130.13/sh−20,362→ 18,289 total
Award
Voyager Therapeutics, Inc.$VYGR
Stock Option (Right to Buy)
2025-06-03+24,000→ 24,000 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,717→ 5,434 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.83/sh−1,432→ 16,846 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,717→ 18,278 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13+2,690→ 19,536 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-02-13$116.75/sh−1,447→ 18,089 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-13−2,690→ 8,070 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Stock Option
2025-02-12+54,645→ 54,645 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-02-12+10,241→ 10,241 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31$152.97/sh−126→ 15,561 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-01-31+238→ 15,687 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-01-31−238→ 238 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-11-29−4,426→ 4,426 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-11-29+4,426→ 17,780 total

Companies

Recent Filings

Address

C/O VOYAGER THERAPEUTICS, INC. 75 HAYDEN AVENUE

LEXINGTON, MA, 02421

View on SEC.gov